Related Experiment Videos
The problem of uncontrolled hypertension.
1Department of Public Health and Clinical Medicine, Norrlands University Hospital, Umeå, Sweden. larsh.lindholm@fammed.umu.se
Journal of Human Hypertension
|July 26, 2002
Summary
High blood pressure significantly increases cardiovascular risks. Angiotensin II type 1 receptor blockers may improve adherence and control of hypertension due to their tolerability.
Area of Science:
- Cardiology
- Hypertension Management
- Pharmacology
Background:
- Elevated blood pressure is a continuous risk factor for cardiovascular and cerebrovascular diseases.
- Systolic blood pressure is a more significant predictor of risk than diastolic pressure.
- Current guidelines recommend blood pressure targets below 140/90 mm Hg.
Purpose of the Study:
- To highlight the issue of inadequately controlled hypertension in clinical practice.
- To identify factors contributing to poor hypertension control.
- To explore the potential role of Angiotensin II type 1 (AT(1))-receptor blockers in improving treatment adherence.
Main Methods:
- Review of established medical literature on hypertension and cardiovascular risk.
- Analysis of population survey data on hypertension control rates.
- Examination of factors influencing patient adherence to antihypertensive therapy.
Main Results:
- Despite clear evidence, hypertension control rates are often low, with some surveys showing achievement rates of 20% or less.
- Physician focus on diastolic rather than systolic pressure and poor patient adherence contribute to inadequate control.
- Angiotensin II type 1 (AT(1))-receptor blockers exhibit favorable tolerability, potentially improving patient adherence.
Conclusions:
- Inadequate control of hypertension remains a significant clinical challenge.
- Improving patient adherence through well-tolerated medications like AT(1)-receptor blockers is crucial.
- AT(1)-receptor blockers may offer a valuable strategy to improve overall hypertension management and reduce cardiovascular events.